IF
iSelect Fund invests in early-stage companies addressing agriculture, food and healthcare challenges.
AllerFund is an early-stage venture capital firm backing therapies, diagnostics, devices and other products for people living with food allergies.
AllerFund is a venture capital firm focused on technologies and products serving the food allergy community. It invests in early-stage companies across therapeutics, medical devices, diagnostics, digital technologies and consumer products.
Its published portfolio includes Anjo.ai, ATANIS Biotech, Amulet, IgGenix and EvoEndo. The operating firm is AllerFund Ventures, LLC.